BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6957655)

  • 1. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
    Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
    Rutten VP; Klein WR; De Jong WA; Misdorp W; Steerenberg PA; De Jong WH; Den Otter W; Ruitenberg EJ
    Cancer Immunol Immunother; 1991; 34(3):186-90. PubMed ID: 1756535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intratumorally administered mycobacterial cell walls in the treatment of cattle with ocular carcinoma.
    Kleinschuster SJ; Rapp HJ; Green SB; Bier J; van Kampen K
    J Natl Cancer Inst; 1981 Nov; 67(5):1165-71. PubMed ID: 6946252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprophylaxis of an ocular solid malignant tumor in cattle.
    Kleinschuster SJ; Rapp HJ; Bier J; Muscoplat CC; Smart RA; Van Kampen KR
    J Natl Cancer Inst; 1983 Apr; 70(4):771-6. PubMed ID: 6572763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of bovine ocular squamous cell carcinoma: isolation, culture and characterization of lymphocytes present in the tumor.
    Rutten VP; De Jong WA; Klein WR; Den Otter W; Steerenberg PA; Ruitenberg EJ
    Anticancer Res; 1991; 11(3):1259-64. PubMed ID: 1888157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.
    Klein WR; Steerenberg PA; Poelma F; vd Wiel E; Rutten VP; Misdorp W; de Jong WH; Ruitenberg EJ
    Cancer Immunol Immunother; 1986; 22(2):87-94. PubMed ID: 3719596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy of squamous cell carcinoma of the bovine eye and of equine sarcoid].
    Klein WR
    Tijdschr Diergeneeskd; 1990 Dec; 115(24):1149-55. PubMed ID: 2264025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine.
    Kleinschuster SJ; Rapp HJ; Lueker DC; Kainer RA
    J Natl Cancer Inst; 1977 Jun; 58(6):1807-14. PubMed ID: 864757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bovine and equine ocular squamous cell carcinoma by radiofrequency hyperthermia.
    Grier RL; Brewer WG; Paul SR; Theilen GH
    J Am Vet Med Assoc; 1980 Jul; 177(1):55-61. PubMed ID: 7429940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathological aspects of immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma.
    Misdorp W; Klein WR; Ruitenberg EJ; Hart G; de Jong WH; Steerenberg PA
    Cancer Immunol Immunother; 1985; 20(3):223-30. PubMed ID: 3851702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotransplantation of bovine ocular squamous cell carcinoma and effects on primary tumor growth.
    Dennis MW; Kainer RA; Lueker DC
    Am J Vet Res; 1984 Jun; 45(6):1225-9. PubMed ID: 6742585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunologic therapy of squamous cell carcinoma. A preliminary report.
    Van Kampen KR; Crisp WE; De Martini JC; Ellsworth HS
    Trans Pac Coast Obstet Gynecol Soc; 1972; 40():129-34. PubMed ID: 4668176
    [No Abstract]   [Full Text] [Related]  

  • 13. Host response to bovine ocular squamous cell carcinoma.
    Dennis MW; Lueker DC; Kainer RA
    Am J Vet Res; 1985 Sep; 46(9):1975-9. PubMed ID: 4051302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The present status of BCG treatment in the veterinary practice.
    Klein WR; Rutten VP; Steerenberg PA; Ruitenberg EJ
    In Vivo; 1991; 5(6):605-8. PubMed ID: 1810446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
    Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
    Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manifestations of immunotherapy in cases of bovine ocular squamous cell carcinoma.
    Heck FC; England RB
    Vet Med Small Anim Clin; 1977 Nov; 72(11):1767-73. PubMed ID: 244161
    [No Abstract]   [Full Text] [Related]  

  • 17. Intratumoral bcg cell-wall preparation therapy and surgery in bovine ocular carcinoma.
    Kleinschuster SJ; Bier J; Rapp HJ; Smart RA; Van Kampen KR; Walters JL
    Head Neck Surg; 1983; 5(5):401-9. PubMed ID: 6874364
    [No Abstract]   [Full Text] [Related]  

  • 18. Local interleukin-2 and interleukin-12 therapy of bovine ocular squamous cell carcinomas.
    Stewart RJ; Masztalerz A; Jacobs JJ; Den Otter W
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):277-84. PubMed ID: 15963825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Cancer eye" in German spotted cattle. Occurrence, treatment methods and results].
    Köstlin RG; Jonek JE
    Tierarztl Prax; 1986; 14(4):477-90. PubMed ID: 3547767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.